Jeffrey V. May, PhD
Jeffrey V. May, PhD
Research Associate Professor, Department of Biological Sciences
Office: 438 Hubbard Hall
Lab: 437 Hubbard Hall
Phone: (316) 978-6177
Fax: (316) 378-3772
Adjunct Associate Professor, Dept. of Medical Sciences, School of Medicine-Wichita,
University of Kansas Medical Center, Wichita, Kansas
Current Grant Activity
Honors and Other Activities
Courses Previously Taught
|University of Maine||B.S.||1970||Biochemistry|
|University of Rhode Island||Ph.D.||1979||Biochemistry|
|Duke University Medical Center||Postdoctoral Fellowship||1979 - 1982||Reproductive Biology|
|2002 - 2009||Associate Professor, Dept. of Biological Sciences, Wichita State University, Wichita, KS|
|2002 - 2004||Executive Director, H.L. Snyder Medical Research Institute, Winfield, KS|
|1993 - 2002||Scientific Director, The Women's Research Institute, Wichita, KS|
|1987 - 2002||Senior Scientist, The Women's Research Institute, Wichita, KS|
|1991 - 2002||Associate Professor, Dept. of Ob/Gyn, Un. of KS School of Medicine-Wichita, Wichita, KS|
|1995 - 2002||Adjunct Professor, Dept. of Biological Sciences, Wichita State University, Wichita, KS|
|1988 - 1997||Director, Assisted Reproductive Technology Lab, The Center for Reproductive Medicine, Univ. of KS School of Medicine-Wichita, Wichita, KS|
|1987 - 1991||Assistant Professor, Dept. of Ob/Gyn, Univ. of KS School of Medicine-Wichita, Wichita, KS|
|1982 - 1987||Assistant Professor of Ob/Gyn (non-tenure track) and Assistant Professor of Physiology, Duke University Medical Center, Durham, NC|
I am a mammalian reproductive biologist with a fundamental interest in ovarian function. This includes: the mechanisms underlying folliculogenesis focusing on the role of somatic cells in regulating this process; factors governing early embryo development; clinical infertility; and ovarian cancer. I am part of a NIH-funded Program Project investigating the differential activity and function of human FSH glycoforms upon reproductive function and how these glycoforms change as a function of age. Numerous techniques are utilized to address the above research areas including primary cell culture, molecular biology, biochemistry, and morphological analysis.
|Grant #: 5P01-AG029531-02
[NIH, NIA] (Bousfield, PI)
|04/01/09 - 02/28/14||Title: The Aging Pituitary/Gonadal Axis||$6,622,855
|Roles: Co-Leader, Core A-Administrative Core
Leader, Core B - FSH Preparation, Purification and Analysis Laboratory
[NCRR] (Hendry, PI)
|07/01/10 - 06/30/11||Title: Wichita State University Combined Core Facility Renovation Project||$2,109,094
|Role: Grant Proposal Author & Project Manager. The application was organizae and written entirely by Dr. May who is responsible for progress and completion of the project.|
|K-INBRE Core Facility Grant||05/01/11 - 04/30/12||Title: WSU P01 Core Lab Roller Bottle Incubator||$18,557||Role: Principal Investigator|
- Jiang, C, Hou, X, Bousfield, G, May, JV, Butnev, V, Roy, S, Davis, JS (2014). Role of glycosylation in FSH signaling in ovarian cells. In Preparation for sumission to Mol Endocrinology.
- Davis, JS, Kumar, R, May, JV, Bousfield, GR (2104) Naturally Occurring Follicle-Stimulating Hormone Glycosylation Variants. J. Glycomics Lipodomics 4:1-5.
- Bousfield GR, Butnev, VY, Butnev, VY, Hiromasa, Y, Harvey, DJ, May, JV (2014) Hypoglycosylated human follicle-stimulating hormone (hFSH21/18) is much more active in vitro than fully glycosylated hFSH (hFSH24). Mol Cell Endocrinol 382: 989-997.
- Alwis, ID, Maroni, DM, Hendry, IR, Roy, SK, May, JV, Leavitt, WW, Hendry WJ. (2011) Evidence In the hamster that neonatal diethylstilbestrol exposure disrupts ovarian structure/function via both direct and indirect mechanisms. Under revision for publication in Reproductive Toxicology.
- Jiang, C, Hou, X, Bousfield, G, May, JV, Butnev, V, Roy, S, Davis, JS (2012). Role of glycosylation in FSH signaling in ovarian cells. In Preparation for submission to Endocrinology.
- Butnev, VY, May, JV, Davis, JS, Bousfield, GR (2012). Characterization of di- and tetra-glycosylated hFSH glycoform. In preparation for submission
Kansas-IDEA Network of Biomedical Research Excellence (K-INBRE): Faculty Scholar Award,
NIH Study Section- Regular, 4-year Membership:
Previous - RAG, 10/15/2008 – 6/30/2012, extended through 2013
Previous - REB , 09/12/1994-06/30/1998
NIH Ad Hoc Member: RAG, 6/25-26/2007; ICER, 10/5-6/2006; CMIR, 6/21-22/2004; REB, 06/02-04/2003, 10/04-06/1993; 6/23-23/1993; BCE, 05/10-12/1992
NIH Special Study Sections: Cooperative Specialized Infertility Research Center Program (U-54), NICHD, 4/8-11/1996; P-50 Site Visit Team DRG, NIH 9/28-30/1995; Special Emphasis Panel, NICHD, NIH, 4/24/1998; Special Emphasis Panel, CSR, NIH, SBIR/STTR Grant Review, 3/29-30/1999 and 11/15-16/1999, Special Emphasis Review Panel, K08 grant review, 7/31/2002.
NIH Ad Hoc Grant Reviewer: MABS, 3/2005, 10/2005, 10/2006; EMNR-A02M, 10/2005; BCE, 12/1989, 5/1991.
Grant Reviewer: USDA 04/1990, 05/1991; and NSF 09/19/90.
Editorial Board: Endocrinology 1993-1996; American Journal of Physiology (Endocrinology/Metabolism) 1995-1997, 1998-2002
Consultant: Food and Drug Administration, DHHS, Ob/Gyn Devices Panel, 1996-2004
High Complexity Clinical Lab Director (HCLD) The American Board of Bioanalysis, 1994-2000
Laboratory Inspector, Reproductive Accreditation Program, College of American Pathologists, 1993-1996
|BIOL 210||General Biology I|
|BIOL 420||Molecular Cell Biology|
|BIOL 540||Developmental Biology|
|BIOL 626/640||Reproductive Biology|